Search

everythinglearnresearchcommunity

for

Search:↓

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

TURP specimens should be checked for various tumors, not just common prostate issues.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Different forms of finasteride dissolve and remain stable differently, affecting capsule quality.

Good nutrition is crucial for health and preventing disease, and supplements can help prevent nutrient deficiencies.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Antiandrogens may help treat conditions like excessive hair growth, prostate tumors, male baldness, and acne by blocking male hormone effects.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

α-spinasterol from Melandrium firmum can help reduce prostate enlargement.